Prostate Cancer

Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China. June 2, 2023

The role of AI in prostate MRI quality and interpretation: Opportunities and challenges. June 2, 2023

A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database. June 2, 2023

Symptom appraisal and help seeking in males with symptoms of possible prostate cancer: a qualitative study with an ethnically diverse sample in London. June 2, 2023

Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. June 2, 2023

Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer June 1, 2023

LYNPARZA® (Olaparib) plus Abiraterone Approved in the US for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer June 1, 2023

FDA Approves Olaparib with Abiraterone and Prednisone (Or Prednisolone) for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer June 1, 2023

Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy. June 1, 2023

Using 18F-DCFPyL Prostate-Specific Membrane Antigen-Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy. June 1, 2023

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer. June 1, 2023

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer. June 1, 2023

Associations between etiologic or prognostic tumor tissue markers and neighborhood contextual factors in male health professionals diagnosed with prostate cancer. June 1, 2023

Intermediate Grade Prostate Cancer and Risk for Adverse Pathology Radical Prostatectomy: Implications for Partial Gland Ablation Case Selection. May 31, 2023

An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry. May 31, 2023

Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p. May 31, 2023

Regional disparities of prostate cancer mortality in Ecuador: an examination of trends and correlates from 2004 to 2019. May 31, 2023

Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data. May 31, 2023

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies. May 31, 2023

Evaluation of initial prostate cancer biopsies utilizing 3D open-top light-sheet microscopy for detection of early disease. May 31, 2023

Page 1 of 1305